Cargando…
Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment
Glioblastoma (GBM) is the most common malignant tumor of the central nervous system (CNS). It is a leading cause of death among patients with intracranial malignant tumors. GBM exhibits intra- and inter-tumor heterogeneity, leading to drug resistance and eventual tumor recurrence. Conventional treat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347406/ https://www.ncbi.nlm.nih.gov/pubmed/37456742 http://dx.doi.org/10.3389/fphar.2023.1211719 |